drugset / Trial / NCT02163876

Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury

NCT02163876

Phase 2 Terminated 31 enrolled StemCells, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

This study will evaluate the safety and efficacy of human central nervous system stem cell transplantation into patients with traumatic injury in the cervical region of the spinal cord.

Timeline

Start
2014-10
Primary completion
2016-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Rexlemestrocel-L Cell therapy Other

Indications